Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Dante Pieramici, M.D.
483
•Dante Pieramici, M.D.•February 10, 2023

FDA 483 - Dante Pieramici, M.D. - February 10, 2023

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dante Pieramici, M.D.
Record Details

Dante Pieramici, M.D., a clinical investigator in Santa Barbara, CA, was cited for failing to conduct an investigation in accordance with the investigational plan. The primary issue involved multiple temperature excursions for investigational product storage, affecting numerous subjects. This represents a significant deviation from protocol requirements.

Company
Dante Pieramici, M.D.
Inspection Date
February 10, 2023
Product Type
Drugs
Office
Division of Pharmaceutical Quality Operations IV
Person
  • Humberto Z. Gomez (investigator)
Open in Dashboard

ID · 6d01ba23-a995-4a81-82cd-69bb948dbcbe

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.